Access Industries and Pharmstandard-backed immuno-oncology therapy developer Neon Therapeutics floated in the middle of its range.

The personal genomics product supplier has closed a round featuring corporates Illumina and Mayo Clinic after receiving funding from Temasek.

Vanderbilt spinout Appello has been backed by Deerfield Management, which recently launched a $65m commercialisation partnership with the university.

University of Geneva spinout ABCDx has raised an undisclosed amount in its first funding round.

The University of Virginia Licensing and Ventures Group Seed Fund has made its fourth investment, putting an undisclosed sum into 510 Kardiac Devices.

The small-molecule drug developer raised equity funding in an Alexandria Venture Investments-backed round.

Molecular testing system developer Isoma was spun out from Wistar but has also licensed intellectual property from University of Pennsylvania.

UPMC has contributed to a funding round for Xealth, which emerged out of Providence St. Joseph Health.

Harvard spinout eGenesis launched in 2015 in a bid to find a successful mechanism for transplanting pig organs into human beings.